• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人神经母细胞瘤骨转移异种移植模型的建立与鉴定

Establishment and characterization of xenograft models of human neuroblastoma bone metastasis.

作者信息

Zhao Hongyu, Cai Weisong, Li Shuai, Da Zuke, Sun Hanxue, Ma Liang, Lin Yaoxin, Zhi Debao

机构信息

Department of Neurosurgery, Shengjing Hospital, China Medical University, Shenyang, China.

出版信息

Childs Nerv Syst. 2012 Dec;28(12):2047-54. doi: 10.1007/s00381-012-1909-3. Epub 2012 Sep 16.

DOI:10.1007/s00381-012-1909-3
PMID:22983667
Abstract

OBJECTS

To improve the therapy of advanced neuroblastoma (NB), it is critical to develop animal models that mimic NB bone metastases. Unlike the human disease, NB xenograft models rarely metastasize spontaneously to bone from the orthotopic site of primary tumor growth.

METHODS

Single-cell suspensions of SY5Y, KCNR NB cells were injected directly into the femur of nude mice. Radiological and histological analyses and immunohistochemistry analyses were performed to characterize these osseous NB models. SY5Y and KCNR result in osteolytic responses.

RESULTS

We have detected osteoprotegerin, receptor activator of nuclear factor kappa B ligand, parathyroid hormone-related protein, and endothelin-1, proteins associated with bone growth and osteolysis, and C-X-C chemokine receptor type 4 (CXCR4) involved in tumor growth and tumor cell migration in the NB cells grown in the bone.

CONCLUSIONS

These animal models can be used to study biological interactions, pathways, and potential therapeutic targets and also to evaluate new agents for treatment and prevention of NB bone metastasis.

摘要

目的

为改善晚期神经母细胞瘤(NB)的治疗方法,开发能够模拟NB骨转移的动物模型至关重要。与人类疾病不同,NB异种移植模型很少从原发性肿瘤生长的原位自发转移至骨骼。

方法

将SY5Y、KCNR NB细胞的单细胞悬液直接注射到裸鼠的股骨中。进行放射学、组织学分析及免疫组化分析以表征这些骨NB模型。SY5Y和KCNR会引发溶骨性反应。

结果

我们在骨骼中生长的NB细胞中检测到了骨保护素、核因子κB受体活化因子配体、甲状旁腺激素相关蛋白和内皮素-1,这些蛋白与骨生长和骨溶解相关,还检测到了参与肿瘤生长和肿瘤细胞迁移的C-X-C趋化因子受体4(CXCR4)。

结论

这些动物模型可用于研究生物学相互作用、信号通路及潜在治疗靶点,还可用于评估治疗和预防NB骨转移的新药物。

相似文献

1
Establishment and characterization of xenograft models of human neuroblastoma bone metastasis.人神经母细胞瘤骨转移异种移植模型的建立与鉴定
Childs Nerv Syst. 2012 Dec;28(12):2047-54. doi: 10.1007/s00381-012-1909-3. Epub 2012 Sep 16.
2
Characterization of neuroblastoma bone invasion/metastasis in established bone metastatic model of SY5Y and KCNR cell lines.在SY5Y和KCNR细胞系的既定骨转移模型中对神经母细胞瘤骨侵袭/转移的特征分析。
Childs Nerv Syst. 2013 Jul;29(7):1097-105. doi: 10.1007/s00381-013-2086-8. Epub 2013 Apr 5.
3
Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.在新建立的人类神经母细胞瘤模型中,核因子κB受体活化因子配体(RANKL)是破骨细胞形成导致骨转移的关键分子。
Cancer Res. 2001 Feb 15;61(4):1637-44.
4
Establishment and characterization of osseous prostate cancer models: intra-tibial injection of human prostate cancer cells.骨前列腺癌模型的建立与表征:人前列腺癌细胞的胫骨内注射
Prostate. 2002 Jun 1;52(1):20-33. doi: 10.1002/pros.10091.
5
The chemokine receptor CXCR4 strongly promotes neuroblastoma primary tumour and metastatic growth, but not invasion.趋化因子受体CXCR4强烈促进神经母细胞瘤原发性肿瘤和转移生长,但不促进侵袭。
PLoS One. 2007 Oct 10;2(10):e1016. doi: 10.1371/journal.pone.0001016.
6
Biologically relevant orthotopic neuroblastoma xenograft models: primary adrenal tumor growth and spontaneous distant metastasis.具有生物学相关性的原位神经母细胞瘤异种移植模型:原发性肾上腺肿瘤生长和自发性远处转移。
In Vivo. 2002 Mar-Apr;16(2):77-85.
7
In vivo echographic evidence of tumoral vascularization and microenvironment interactions in metastatic orthotopic human neuroblastoma xenografts.转移性原位人神经母细胞瘤异种移植瘤中肿瘤血管生成及微环境相互作用的体内超声证据
Int J Cancer. 2005 Mar 1;113(6):881-90. doi: 10.1002/ijc.20681.
8
Generation and characterization of novel local and metastatic human neuroblastoma variants.新型局部和转移性人类神经母细胞瘤变体的生成与特性分析
Neoplasia. 2008 Aug;10(8):816-27. doi: 10.1593/neo.08402.
9
Establishment of a neuroblastoma mouse model by subcutaneous xenograft transplantation and its use to study metastatic neuroblastoma.通过皮下异种移植建立神经母细胞瘤小鼠模型及其在转移性神经母细胞瘤研究中的应用。
Genet Mol Res. 2015 Dec 8;14(4):16297-307. doi: 10.4238/2015.December.8.20.
10
Lytic bone lesions in human neuroblastoma xenograft involve osteoclast recruitment and are inhibited by bisphosphonate.人神经母细胞瘤异种移植中的溶骨性骨病变涉及破骨细胞募集,并被双膦酸盐抑制。
Cancer Res. 2003 Jun 15;63(12):3026-31.

引用本文的文献

1
Intermittent hypoxia effect on osteoclastogenesis stimulated by neuroblastoma cells.间歇性低氧对神经母细胞瘤细胞刺激的破骨细胞生成的影响。
PLoS One. 2014 Aug 22;9(8):e105555. doi: 10.1371/journal.pone.0105555. eCollection 2014.
2
The role of chemoattractant receptors in shaping the tumor microenvironment.趋化因子受体在塑造肿瘤微环境中的作用。
Biomed Res Int. 2014;2014:751392. doi: 10.1155/2014/751392. Epub 2014 Jul 10.
3
β-Arrestin1 and distinct CXCR4 structures are required for stromal derived factor-1 to downregulate CXCR4 cell-surface levels in neuroblastoma.

本文引用的文献

1
Neuroblastoma: the impact of biology and cooperation leading to personalized treatments.神经母细胞瘤:生物学和合作的影响导致个体化治疗。
Crit Rev Clin Lab Sci. 2012 May-Jun;49(3):85-115. doi: 10.3109/10408363.2012.683483.
2
Ginsenoside Rg1 prevents SK-N-SH neuroblastoma cell apoptosis induced by supernatant from Aβ1-40-stimulated THP-1 monocytes.人参皂苷 Rg1 可预防 Aβ1-40 刺激的 THP-1 单核细胞上清诱导的 SK-N-SH 神经母细胞瘤细胞凋亡。
Brain Res Bull. 2012 Aug 1;88(5):501-6. doi: 10.1016/j.brainresbull.2012.05.002. Epub 2012 May 14.
3
Promising therapeutic targets in neuroblastoma.
β-arrestin1 和独特的 CXCR4 结构对于基质衍生因子-1 下调神经母细胞瘤中 CXCR4 的细胞表面水平是必需的。
Mol Pharmacol. 2014 Apr;85(4):542-52. doi: 10.1124/mol.113.089714. Epub 2014 Jan 22.
4
Target delivery of MYCN siRNA by folate-nanoliposomes delivery system in a metastatic neuroblastoma model.叶酸介导的纳米脂质体载 MYCNsiRNA 靶向递药系统治疗神经母细胞瘤转移的实验研究。
Cancer Cell Int. 2013 Jun 27;13(1):65. doi: 10.1186/1475-2867-13-65.
神经母细胞瘤有前景的治疗靶点。
Clin Cancer Res. 2012 May 15;18(10):2740-53. doi: 10.1158/1078-0432.CCR-11-1939.
4
Regulatory factor X1-induced down-regulation of transforming growth factor β2 transcription in human neuroblastoma cells.调节因子 X1 诱导人神经母细胞瘤细胞中转化生长因子 β2 转录的下调。
J Biol Chem. 2012 Jun 29;287(27):22730-9. doi: 10.1074/jbc.M111.338590. Epub 2012 May 11.
5
Oct4 and Sox2 are overexpressed in human neuroblastoma and inhibited by chemotherapy.Oct4 和 Sox2 在人神经母细胞瘤中过表达,并受化疗抑制。
Oncol Rep. 2012 Jul;28(1):186-92. doi: 10.3892/or.2012.1765. Epub 2012 Apr 20.
6
Emerging treatment options for the treatment of neuroblastoma: potential role of perifosine.神经母细胞瘤治疗的新兴治疗选择:哌立福新的潜在作用
Onco Targets Ther. 2012;5:21-9. doi: 10.2147/OTT.S14578. Epub 2012 Mar 2.
7
Slow down to stay alive: HER4 protects against cellular stress and confers chemoresistance in neuroblastoma.慢下来以保持生机:HER4 可保护神经母细胞瘤免受细胞应激,并赋予其化疗耐药性。
Cancer. 2012 Oct 15;118(20):5140-54. doi: 10.1002/cncr.27496. Epub 2012 Mar 13.
8
Immunocombination therapy for high-risk neuroblastoma.免疫联合疗法治疗高危神经母细胞瘤。
Immunotherapy. 2012 Feb;4(2):163-74. doi: 10.2217/imt.11.169.
9
Cyto-morphologic evaluation of bone marrow in infants with disseminated neuroblastoma.播散性神经母细胞瘤婴儿骨髓的细胞形态学评估
J Pediatr Hematol Oncol. 2012 Mar;34(2):154-8. doi: 10.1097/MPH.0b013e31821d80be.
10
Neuroblastoma with spinal cord compression: is there an emergency treatment of choice?伴有脊髓压迫的神经母细胞瘤:是否存在首选的紧急治疗方法?
Dev Med Child Neurol. 2012 Apr;54(4):297-8. doi: 10.1111/j.1469-8749.2011.04174.x. Epub 2012 Feb 13.